RBA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. While the longer-term trend structure is still bullish (SMA_5 > SMA_20 > SMA_200) and fundamentals are improving, near-term momentum is weakening (MACD histogram below zero and negatively expanding) and the pattern-based forecast points to downside risk over the next month (-8.65%). With no Intellectia buy signals today and price still below the pivot (114.769), the setup is not attractive for an immediate entry.
Price/levels: RBA at 113.24 is below the pivot (114.769) and sitting just above first support S1 (112.325). A clean break below 112.3 increases risk toward S2 (110.814). To regain near-term strength, it likely needs to reclaim the pivot (114.8) and then challenge R1 (117.214).
Trend: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting the broader trend remains up.
Momentum: MACD histogram is negative (-0.0866) and expanding to the downside, signaling weakening momentum. RSI_6 at 42.7 is neutral-to-soft (not oversold), implying there may be room for further drift lower before a momentum reset.
Quant/pattern read: Similar candlestick-pattern analysis implies modest next-day upside (+1.01%) but weakness over the next week (-0.8%) and especially next month (-8.65%), which undermines an “buy-now” decision for a short-horizon trader.
Intellectia Proprietary Trading Signals
on 2026-02-17 after hours could become a catalyst if results/guide are strong.
is close to BofA’s $114 target, reducing “quick win” upside unless momentum improves.
Latest quarter: 2025/Q3. Growth trends were solid: Revenue $1.0927B (+11.30% YoY), Net Income $80.7M (+20.63% YoY), EPS $0.43 (+19.44% YoY). Gross margin improved to 34.68 (+1.14 YoY). Overall, this is a constructive growth/efficiency profile, but the current trade decision is constrained by weakening near-term technical momentum.
Recent changes are net positive. National Bank upgraded to Outperform (PT raised to $124 from $111) and explicitly framed the selloff as a buying opportunity. BofA kept a Buy but trimmed PT to $114 from $120, citing valuation methodology and auto-related overhangs while still sounding increasingly positive into 2026. Wall Street pros: improving setup into 2026, willingness to buy dips, and raised target by one firm. Wall Street cons: valuation/multiple pressure and overhang commentary; near-term PT from BofA is essentially at today’s price. Influential/political trading: No recent congress trading data available; insiders show no significant recent trend (neutral).
